Cited by 46Sexual function and dysfunction studiesCancer survivorship and careProstate Cancer Treatment and Research

Effect of androgen deprivation therapy on sexual function and bother in men with prostate cancer: a controlled comparison

Open access
Donovan, Kristine A., Gonzalez, Brian D., Nelson, Ashley M., Fishman, Mayer N., Zachariah, Babu, Jacobsen, Paul B.·2018·Psycho-Oncology

Abstract

OBJECTIVES: The adverse sexual effects of androgen deprivation therapy (ADT) on men with prostate cancer have been well described. Less well known is the relative degree of sexual dysfunction and bother associated with ADT compared to other primary treatment modalities such as radical prostatectomy. We sought to describe the trajectory and relative magnitude of changes in sexual function and bother in men on ADT and to examine demographic and clinical predictors of ADT's adverse sexual effects. METHODS: Prostate cancer patients treated with ADT (n = 60) completed assessments of sexual function and sexual bother 3 times during a 1-year period after the initiation of ADT. Prostate cancer patients treated with radical prostatectomy only and not receiving ADT (n = 85) and men with no history of cancer (n = 86) matched on age and education completed assessments at similar intervals. RESULTS: Androgen deprivation therapy recipients reported worsening sexual function and increasing bother over time compared to controls. Effect sizes for the differences in sexual function were large to very large, and for bother were small to very large. Age younger than 83 years predicted relatively poorer sexual function, and age younger than 78 years predicted greater sexual bother at 12 months in men on ADT compared to men not on ADT. CONCLUSIONS: Most men on ADT for prostate cancer will never return to baseline levels of sexual function. Interventions focused on sexual bother over function and designed to help couples build and maintain satisfying relationship intimacy are likely to more positively affect men's psychological well-being while on ADT than medical or sexual aids targeting sexual dysfunction.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/pon.4463

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In older men with prostate cancer, androgen deprivation achieving castrate levels of circulating testosterone for 12 months markedly suppressed sexual desire and function, unlike in controls.

    “in a well-controlled prospective study of older men with prostate cancer (66), androgen deprivation achieving castrate levels of circulating testosterone sustained during 12 months markedly suppressed sexual desire and function, whereas those effects did not occur in age-matched men having nonhormonal treatment of prostate cancer or those without prostate cancer.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [32]Sanda MG Dunn RL Michalski J Quality of life and satisfaction with outcome among prostate-cancer survivors N Engl J Med 2008 358 1250 1261 18354103

Cited by

Sorted by citations

Authors
Donovan, K. A., Gonzalez, B. D., Nelson, A. M., Fishman, M. N., Zachariah, B., & Jacobsen, P. B.
Affiliations
  • Moffitt Cancer Center (US)
  • University of South Florida (US)
  • James A. Haley Veterans' Hospital (US)
Corresponding author
Donovan, Kristine A.
Venue
Psycho-Oncology
Publisher
Wiley
Published
2017-06-27
Volume
27
Issue
1
Pages
316-324
ISSN
  • 1057-9249 (ISSN-L)
  • 1099-1611
OpenAlex
W2617324199
Cited by
46
References
39
Citations by year
2026: 6 · 2025: 6 · 2024: 5 · 2023: 4 · 2022: 6 · 2021: 4 · 2020: 6 · 2019: 4 · 2018: 4 · 2017: 1
FWCI
3.36
Type
journal article
Language
en
Open access
Locations
  • Psycho-Oncology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Digital Commons - University of South Florida (University of South Florida) (submittedVersion)
Funders
  • Division of Cancer Prevention, National Cancer Institute
  • National Cancer Institute (R01 CA132803, R25 CA090314)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Prostate Cancer Treatment and Research
Keywords
androgen deprivation therapy, prostate cancer, sexual dysfunction, sexual bother, radical prostatectomy, predictors of sexual dysfunction, age, relationship intimacy, male sexual health
MeSH terms
Adaptation, Psychological, Aged, Androgen Antagonists, Humans, Male, Middle Aged, Prostatic Neoplasms, Quality of Life, Sexual Behavior, Sexual Dysfunction, Physiological, Sexual Partners, Case-Control Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review